MIRA Pharmaceuticals (MIRA) Financials: Revenue & Earnings
MIRA$0.56+0.01 +1.11%
$23.37M
Market Cap
—
P/E
—
Forward P/E
—
Score
MIRA Pharmaceuticals (MIRA) Financials: Revenue & Earnings
MIRA price $0.56 +0.01 +1.11%
- Ticker
- MIRA
- Price
- $0.56
- Change
- +0.01 +1.11%
- Market cap ?
- $23.37M
- Beta ?
- 1.49
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
Fair value
MIRA fair value Not meaningful. Price $0.56.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-12-02 | — | -0.03 | — | — |
| 2026-08-12 | -0.03 | — | — | — |
| 2026-05-14 | -0.03 | — | — | — |
| 2026-03-31 | -0.15 | -0.04 | — | — |
| 2025-11-13 | -1.18 | -1.18 | — | — |
| 2025-08-14 | -0.09 | -0.11 | — | — |
| 2025-05-14 | -0.11 | -0.15 | — | — |
| 2025-03-28 | -0.15 | -0.29 | 11.16M | — |
| 2024-11-12 | -0.14 | -0.18 | — | — |
| 2024-08-13 | -0.11 | -0.10 | — | — |
| 2024-05-13 | -0.12 | -0.10 | — | — |
| 2024-04-01 | -0.39 | -0.23 | — | — |
| 2023-11-13 | -0.26 | -0.08 | — | — |
| 2023-09-15 | -0.10 | — | — | — |
| 2023-06-29 | -0.09 | — | — | — |
| 2022-12-31 | -43.86 | — | — | — |
| 2022-09-30 | -0.12 | — | — | — |
| 2022-06-30 | -0.16 | — | — | — |
| 2022-03-31 | -0.10 | — | — | — |
| 2021-03-31 | -0.00 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Whalen Matthew Pratt | Buy | 50.00K | $0.94 | 47.00K |
| 2026-06-12 | Del Giudice Matthew Paul | Buy | 50.00K | $0.94 | 47.00K |
| 2026-06-12 | MacPherson Edward Clouston | Buy | 50.00K | $0.94 | 47.00K |
| 2026-06-12 | Shekhat Denil Nanji | Buy | 50.00K | $0.94 | 47.00K |
| 2026-06-02 | Mushak Andriy | Other | 0 | — | — |
| 2026-03-30 | Aminov Erez | Buy | 83.50K | — | — |
| 2025-12-17 | Aminov Erez | Buy | 3.16M | $1.45 | 4.57M |
| 2025-10-16 | Aminov Erez | Buy | 379.00K | $0.84 | 318.36K |
| 2025-10-16 | Aminov Erez | Buy | 234.59K | $1.16 | 272.13K |
| 2025-10-16 | Aminov Erez | Sell | 613.60K | $2.11 | 1.29M |
| 2025-10-16 | Aminov Erez | Buy | 379.00K | $0.84 | 318.36K |
| 2025-10-16 | Aminov Erez | Buy | 234.59K | $1.16 | 272.13K |
| 2025-10-01 | Shekhat Denil Nanji | Buy | 22.38K | $1.35 | 30.21K |
| 2025-10-01 | Aminov Erez | Buy | 2.69M | — | — |
| 2025-09-18 | Aminov Erez | Buy | 150.00K | $1.38 | 207.00K |
| 2025-08-29 | Aminov Erez | Buy | 62.50K | $1.37 | 85.62K |
| 2025-05-15 | Weichselbaum Alan | Other | 75.00K | $1.18 | 88.50K |
| 2025-03-26 | Aminov Erez | Buy | 62.50K | $1.45 | 90.62K |
| 2025-03-26 | Aminov Erez | Buy | 62.50K | $1.45 | 90.62K |
| 2024-12-09 | Whalen Matthew Pratt | Buy | 25.00K | $1.19 | 29.75K |
| 2024-12-09 | MacPherson Edward Clouston | Buy | 25.00K | $1.19 | 29.75K |
| 2024-12-09 | Yanez Michelle | Buy | 150.00K | $1.19 | 178.50K |
| 2024-12-09 | Aminov Erez | Buy | 2.00M | $1.19 | 2.38M |
| 2024-12-09 | Aminov Erez | Buy | 500.00K | — | — |
| 2024-12-09 | Shekhat Denil Nanji | Buy | 50.00K | $1.19 | 59.50K |
| 2024-12-09 | Del Giudice Matthew Paul | Buy | 25.00K | $1.19 | 29.75K |
| 2024-11-20 | Aminov Erez | Sell | 44.59K | $1.27 | 56.63K |
| 2024-11-19 | Aminov Erez | Sell | 55.41K | $1.39 | 77.02K |
| 2024-11-18 | Whalen Matthew Pratt | Other | 0 | — | — |
| 2024-08-28 | McNulty Brian Patrick | Sell | 200.00K | $1.96 | 392.00K |
| 2024-06-18 | Shekhat Denil Nanji | Buy | 50.00K | $0.71 | 35.50K |
| 2024-05-28 | Aminov Erez | Buy | 379.00K | $0.84 | 318.36K |
| 2024-05-21 | Aminov Erez | Buy | 800 | $0.97 | 776 |
| 2024-05-21 | Aminov Erez | Buy | 800 | $1.01 | 808 |
| 2024-05-21 | Aminov Erez | Buy | 600 | $0.87 | 522 |
| 2024-05-21 | Aminov Erez | Buy | 1.00K | $0.85 | 850 |
| 2024-05-21 | Aminov Erez | Buy | 2.00K | $0.84 | 1.68K |
| 2024-05-21 | Aminov Erez | Buy | 500 | $1.02 | 510 |
| 2024-05-21 | Aminov Erez | Buy | 1.00K | $1.03 | 1.03K |
| 2024-05-21 | Aminov Erez | Buy | 2.00K | $1.00 | 2.00K |
| 2024-03-26 | Aminov Erez | Buy | 300.00K | $1.15 | 345.00K |
| 2024-03-26 | Yanez Michelle | Buy | 150.00K | $1.15 | 172.50K |
| 2024-03-25 | Shekhat Denil Nanji | Buy | 50.00K | $1.16 | 58.00K |
| 2024-03-25 | Jerman Michael Allen | Buy | 50.00K | $1.16 | 58.00K |
| 2024-03-25 | MacPherson Edward Clouston | Buy | 50.00K | $1.16 | 58.00K |
| 2024-03-25 | Del Giudice Matthew Paul | Buy | 50.00K | $1.16 | 58.00K |
| 2024-03-13 | Shekhat Denil Nanji | Other | 0 | — | — |
| 2024-03-13 | Del Giudice Matthew Paul | Other | 0 | — | — |
| 2024-03-13 | MacPherson Edward Clouston | Other | 0 | — | — |
| 2023-08-02 | Vorhoff David C | Sell | 0 | — | — |
| 2023-08-02 | Vorhoff David C | Sell | 10.00K | $5.00 | 50.00K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 26, holders 0 vs prior quarter. Ownership 5.51%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 751.80K | 57.89K | +8.34% | 711.96K |
| CROSS STAFF INVESTMENTS INC | 359.40K | 0 | 0.00% | 340.17K |
| GEODE CAPITAL MANAGEMENT, LLC | 303.88K | 12.99K | +4.47% | 287.62K |
| BLACKROCK, INC. | 244.62K | 132.28K | +117.74% | 231.53K |
| VANGUARD FIDUCIARY TRUST CO | 170.67K | 1.19K | +0.70% | 161.62K |
| CAPTRUST FINANCIAL ADVISORS | 90.64K | 90.64K | New | 85.80K |
| NORTHERN TRUST CORP | 67.73K | 37 | +0.05% | 64.11K |
| FIRST AMERICAN BANK | 60.00K | 0 | 0.00% | 56.79K |
| COMMONWEALTH EQUITY SERVICES, LLC | 53.19K | 18.12K | +51.68% | 50.34K |
| STATE STREET CORP | 49.10K | 0 | 0.00% | 46.47K |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 35.00K | 0 | 0.00% | 33.16K |
| FIFTH THIRD BANCORP | 20.00K | 0 | 0.00% | 18.93K |
| CITADEL ADVISORS LLC | 18.66K | 18.66K | New | 17.66K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 18.57K | -6.58K | -26.17% | 17.57K |
| MARINER, LLC | 16.50K | 0 | 0.00% | 15.62K |
| XTX TOPCO LTD | 16.37K | -21.20K | -56.42% | 15.50K |
| HRT FINANCIAL LP | 13.45K | 13.45K | New | 12.00K |
| CARY STREET PARTNERS FINANCIAL LLC | 10.00K | 0 | 0.00% | 9.46K |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 8.00K | 0 | 0.00% | 7.58K |
| OSAIC HOLDINGS, INC. | 2.00K | 0 | 0.00% | 1.90K |
| UBS GROUP AG | 1.77K | -4.68K | -72.55% | 1.68K |
| CITIGROUP INC | 1.21K | -3.02K | -71.44% | 1.14K |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 1.00K | -1.00K | -50.00% | 947 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 517 | -4.46K | -89.61% | 489 |
| BARCLAYS PLC | 159 | 159 | New | 150 |
Earnings and financials
MIRA Pharmaceuticals, Inc. (MIRA) trades at $0.56, with a market cap of $23.37M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn